Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-02-13 to 2025-02-14
Current total value of award: $17164.44
Description: 4567338480!NUCALA 40 MG/0.4 ML SYRINGE 0.4ML